KAT2B and breast cancer: Specifically, we showed that NELF activates the EMT and mammary stem cell transcriptional programs in breast cancer, and defined an epigenetic mechanism by which NELF co-opts the EMT TF, SLUG, and histone acetyltransferase, KAT2B, to coordinate gene expression reprogramming during EMT.